STOCK TITAN

Turn Therapeutics (TTRX) CEO and 10% owner report 1.2M-share stock gifts

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Turn Therapeutics Inc. director and Chief Executive Officer Bradley E. Burnam reported a series of bona fide gifts of the company’s common stock on May 28, 2026. The filing shows four gift transactions totaling 1,200,000 shares, each recorded at a price of $0.0000 per share, meaning no cash changed hands.

Part of the stock is held and transferred through BEB Holdings, LLC, where Burnam is the sole member with sole voting and dispositive power. Other portions were gifted to two 2026 revocable trusts established for his daughter and son. The filing states Burnam disclaims beneficial ownership of the shares held by these trusts for Section 16 and other purposes.

Positive

  • None.

Negative

  • None.
Insider Burnam Bradley Evan, BEB Holdings, LLC
Role Chief Executive Officer | null
Type Security Shares Price Value
Gift Common Stock 300,000 $0.00 --
Gift Common Stock 300,000 $0.00 --
Gift Common Stock 300,000 $0.00 --
Gift Common Stock 300,000 $0.00 --
Holdings After Transaction: Common Stock — 15,416,260 shares (Indirect, By BEB Holdings, LLC)
Footnotes (1)
  1. Represents shares of common stock held by BEB Holdings, LLC. The reporting person is the sole member of BEB Holdings, LLC and has sole voting and dispositive power with regard to the shares held by BEB Holdings, LLC. Accordingly, all shares held by BEB Holdings, LLC may be deemed to be beneficially owned by the reporting person. This transaction involved the reporting person's gift of 300,000 shares of common stock to the Bradley E. Burnam 2026 Revocable Trust FBO Gabriella G. Burnam (the "GGB Trust"). The sole beneficiary of the GGB Trust is the reporting person's daughter. The reporting person disclaims beneficial ownership of the securities held by the GGB Trust, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. This transaction involved the reporting person's gift of 300,000 shares of common stock to the Bradley E. Burnam 2026 Revocable Trust FBO Luca M. Burnam (the "LMB Trust"). The sole beneficiary of the LMB Trust is the reporting person's son. The reporting person disclaims beneficial ownership of the securities held by the LMB Trust, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Total shares gifted 1,200,000 shares Aggregate bona fide gifts of common stock on May 28, 2026
Per-transaction gift size 300,000 shares Each of four bona fide gift transactions
Gift price per share $0.0000 per share Reported transaction price for all gifted common stock
BEB Holdings LLC position 15,416,260 shares Common stock held indirectly through BEB Holdings, LLC after a reported transaction
Gift transaction count 4 transactions Number of bona fide gift transfers of common stock
bona fide gift financial
"transaction_code_description: "Bona fide gift" for each reported transfer"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
indirect ownership financial
"direct_or_indirect: "I" and nature_of_ownership referencing BEB Holdings, LLC"
beneficially owned financial
"all shares held by BEB Holdings, LLC may be deemed to be beneficially owned by the reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
disclaims beneficial ownership financial
"The reporting person disclaims beneficial ownership of the securities held by the GGB Trust"
Section 16 regulatory
"beneficial owner of the securities for purposes of Section 16 or for any other purpose"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Burnam Bradley Evan

(Last)(First)(Middle)
C/O TURN THERAPEUTICS INC.
250 N. WESTLAKE BLVD.

(Street)
WESTLAKE VILLAGE CALIFORNIA 91362

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Turn Therapeutics Inc. [ TTRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/28/2026G300,000D$015,416,260IBy BEB Holdings, LLC(1)
Common Stock05/28/2026G300,000A$0300,000ISee footnote(2)
Common Stock05/28/2026G300,000D$015,116,260IBy BEB Holdings, LLC(1)
Common Stock05/28/2026G300,000A$0300,000ISee footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
Burnam Bradley Evan

(Last)(First)(Middle)
C/O TURN THERAPEUTICS INC.
250 N. WESTLAKE BLVD.

(Street)
WESTLAKE VILLAGE CALIFORNIA 91362

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
1. Name and Address of Reporting Person*
BEB Holdings, LLC

(Last)(First)(Middle)
C/O TURN THERAPEUTICS INC.
250 N. WESTLAKE BLVD.

(Street)
WESTLAKE VILLAGE CALIFORNIA 91362

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. Represents shares of common stock held by BEB Holdings, LLC. The reporting person is the sole member of BEB Holdings, LLC and has sole voting and dispositive power with regard to the shares held by BEB Holdings, LLC. Accordingly, all shares held by BEB Holdings, LLC may be deemed to be beneficially owned by the reporting person.
2. This transaction involved the reporting person's gift of 300,000 shares of common stock to the Bradley E. Burnam 2026 Revocable Trust FBO Gabriella G. Burnam (the "GGB Trust"). The sole beneficiary of the GGB Trust is the reporting person's daughter. The reporting person disclaims beneficial ownership of the securities held by the GGB Trust, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
3. This transaction involved the reporting person's gift of 300,000 shares of common stock to the Bradley E. Burnam 2026 Revocable Trust FBO Luca M. Burnam (the "LMB Trust"). The sole beneficiary of the LMB Trust is the reporting person's son. The reporting person disclaims beneficial ownership of the securities held by the LMB Trust, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
/s/ Bradley Burnam06/01/2026
/s/ Bradley Burnam, sole member of BEB Holdings, LLC06/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Turn Therapeutics (TTRX) report on this Form 4?

Turn Therapeutics reported four insider transactions classified as bona fide gifts of common stock. Together they cover 1,200,000 shares, with each gift recorded at a price of $0.0000 per share, indicating no sale proceeds were received.

Who is the insider involved in the latest Turn Therapeutics (TTRX) Form 4?

The filing names Bradley E. Burnam, a director, Chief Executive Officer, and a ten percent owner of Turn Therapeutics. It also lists BEB Holdings, LLC as a ten percent owner involved in indirect holdings and gift transfers of the company’s common stock.

How many Turn Therapeutics (TTRX) shares were gifted in the reported transactions?

The Form 4 shows a total of 1,200,000 shares of Turn Therapeutics common stock treated as bona fide gifts. These are reported as four separate 300,000-share transactions, all on May 28, 2026, with no cash consideration per share.

Were the Turn Therapeutics (TTRX) insider transactions sales or gifts?

The transactions were reported as bona fide gifts, not sales. Each is coded with transaction code G and a transaction action of gift transfer, with a stated transaction price per share of $0.0000, confirming no sale proceeds were generated.

What role does BEB Holdings, LLC play in Turn Therapeutics (TTRX) insider holdings?

BEB Holdings, LLC holds shares of Turn Therapeutics common stock attributed to Bradley E. Burnam. The filing notes he is the sole member with sole voting and dispositive power, so shares held by BEB Holdings, LLC may be deemed beneficially owned by him.

How are the gifted Turn Therapeutics (TTRX) shares held for the insider’s family?

Some gifted shares were transferred to two Bradley E. Burnam 2026 Revocable Trusts, one for his daughter and one for his son. The filing explains he disclaims beneficial ownership of securities held by these trusts for Section 16 and any other purpose.